Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,368 | -31,612 | -22,228 | -10,400 | -26,177 |
| Depreciation Amortization | 1,999 | 1,486 | 906 | 441 | 2,523 |
| Accounts receivable | 2,057 | 2,505 | 1,386 | 49 | -1,209 |
| Other Working Capital | 364 | 504 | 547 | -155 | -7,112 |
| Other Operating Activity | 2,618 | 1,743 | 1,252 | 1,103 | -2,588 |
| Operating Cash Flow | $-30,330 | $-25,374 | $-18,137 | $-8,962 | $-34,563 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -688 | -792 | -467 | -287 | 4,481 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 5 |
| Purchase Sale Intangibles | -255 | -255 | -255 | -155 | N/A |
| Other Investing Activity | -655 | -655 | -655 | -355 | -800 |
| Investing Cash Flow | $-1,343 | $-1,447 | $-1,122 | $-642 | $3,686 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 0 | N/A | 27,000 |
| Debt Repayment | -1,962 | -1,303 | 0 | N/A | -22,304 |
| Common Stock Issued | 23,152 | 22,716 | 18,698 | 9,033 | 18,225 |
| Other Financing Activity | 9,684 | -2,236 | -2,189 | -2,138 | -2,149 |
| Financing Cash Flow | $30,874 | $19,177 | $16,509 | $6,895 | $20,772 |
| Exchange Rate Effect | -85 | -13 | 4 | 3 | -106 |
| Beginning Cash Position | 15,506 | 15,506 | 15,506 | 15,506 | 25,717 |
| End Cash Position | 14,622 | 7,849 | 12,760 | 12,800 | 15,506 |
| Net Cash Flow | $-884 | $-7,657 | $-2,746 | $-2,706 | $-10,211 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,330 | -25,374 | -18,137 | -8,962 | -34,563 |
| Capital Expenditure | -764 | -792 | -467 | -287 | -519 |
| Free Cash Flow | -31,094 | -26,166 | -18,604 | -9,249 | -35,082 |